1.
|
Pancreatic ductal adenocarcinoma (PDAC) has the lowest 5-year survival rate of all major malignancies (11%). In particular, late-stage malignancies have only a 5% 5-year [...]
2022 |
Dissertation |
|
2.
|
Pancreatic Ductal Adenocarcinoma (PDAc) ranks among the top three most aggressive cancers in the United States and is projected to increase in incidence over the next few [...]
2024-09-20 |
Dissertation |
|
3.
|
This cancer cell-intrinsic GOT2-PPARĪ“ axis promotes spatial restriction of both CD4+ and CD8+ T cells from the tumor microenvironment, and fosters the immune-suppressive [...]
2021 |
Dissertation |
|
4.
|
In order to improve treatment for a variety of forms of cancer, improved basic understanding of tumor microenvironments is needed. In this thesis, I review the state of t [...]
2021 |
Dissertation |
|
5.
|
|
6.
|
Cachexia is a devastating syndrome with cardinal features of anorexia, weight loss, and fatigue. This syndrome occurs during numerous chronic diseases, such as cancer, ci [...]
2019 |
Dissertation |
|
7.
|
Cancer cachexia is a co-morbidity highly prevalent in pancreatic ductal adenocarcinoma (PDAC) patients and results in a decreased quality of life.This work expands on pri [...]
2023-08-22 |
Abstract |
|
8.
|
Miles J. Edwards was a physician and professor. He completed his medical degree at the University of Oregon Medical School (UOMS, now Oregon Health & Science Universi [...]
2005 November 3 |
Interview |
Oral History Collection |
|
9.
|
Illness behaviors, metabolic disturbances, and cognitive injury are common in cancer patients and frequently lead to wasting or cachexia. This devastating state of malnut [...]
2021 |
Dissertation |
|
10.
|
The aim of this research is to utilize MRF techniques to characterize vascularization differences between healthy pancreas tissue and tumorous tissue. To do this, both he [...]
2024-06-07 |
Thesis |
|